BonominiMDaviesSKleophasW, et al. Rationale and design of ELIXIR, a randomized, controlled trial to evaluate efficacy and safety of XyloCore, a glucose-sparing solution for Peritoneal Dialysis. Perit Dial Int. 2024; in press.
2.
MorelleJLambieMÖbergCM,et al.The peritoneal membrane and its role in peritoneal dialysis. Clin J Am Soc Nephrol2024; 19: 244–253.
3.
MorelleJSowAFustinCA, et al.Mechanisms of crystalloid versus colloid osmosis across the peritoneal membrane. J Am Soc Nephrol2018; 29: 1875–1886.
4.
MorelleJMarechalCYuZ, et al.AQP1 Promoter variant, water transport, and outcomes in peritoneal dialysis. N Engl J Med2021; 385: 1570–1580.
5.
HolmesCJ. Glucotoxicity in peritoneal dialysis–solutions for the solution!Adv Chronic Kidney Dis2007; 14: 269–278.
6.
JohnsonDWBrownFGClarkeM, et al.Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol2012; 23: 1097–1107.
7.
HtayHJohnsonDWWigginsKJ, et al.Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev2018; 10: CD007554.
8.
SchaeferBBartosovaMMacher-GoeppingerS, et al.Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis. Kidney Int2018; 94: 419–429.
9.
LiPKCulletonBFArizaA, et al.Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol2013; 24: 1889–1900.
10.
BonominiMPandolfiADi LiberatoL, et al.L-carnitine is an osmotic agent suitable for peritoneal dialysis. Kidney Int2011; 80: 645–654.
11.
BonominiMDi LiberatoLDel RossoG, et al.Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: A 4-month, prospective, multicenter randomized trial. Am J Kidney Dis2013; 62: 929–938.
12.
BonominiMZammitVDivino-FilhoJC, et al.The osmo-metabolic approach: A novel and tantalizing glucose-sparing strategy in peritoneal dialysis. J Nephrol2021; 34: 503–519.
13.
BazzatoGColiULandiniS, et al.Xylitol as osmotic agent in CAPD: An alternative to glucose for uremic diabetic patients?Trans Am Soc Artif Intern Organs1982; 28: 280–286.
14.
BrownEABlakePGBoudvilleN, et al.International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int2020; 40: 244–253.
